June 3 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback